A Novel Dermocosmetic Routine Containing Vitamin B3 and 2‐Mercaptonicotinyl Glycine Significantly Improves Melasma After 3 Months of Daily Use
Journal of Cosmetic Dermatology · 2025
DOI: 10.1111/jocd.70476 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Juliane Rocio und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Dermatology & Aesthetics of Rio de Janeiro, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Melanosis, Glycine. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Melasma is a chronic refractory pigmentation disorder. Kligman triple (KT) formula is the gold standard. A dermocosmetic (DC) serum containing vitamin B3 and 2‐mercaptonicotinyl glycine has been developed for melasma. This study assessed the benefits of DC serum compared to KT in melasma. Material and Methods A randomized, single‐blind 6‐month study was conducted in women with melasma. Subjects were randomized to Group A (morning: serum; evening: cream, for 6 months) or to Group B (1st 3 months: morning: skin hydrating gel; evening: KT, followed by 3 months of DC routine regimen); all subjects applied a sunscreen with an SPF 50+ twice daily. Assessments included MASI, mMASI, IGA, skin hydration, radiance and fine wrinkles, tolerance, and quality of life (QoL) using MELASQOL.
Results
Ninety‐one women aged 44 ± 6 years of Phototypes III (30%) and IV (36%) were recruited. Both regimens significantly ( p < 0.05) improved MASI after 3 months. A clinically relevant difference in favor of KT was observed. Three months after the switch, both Group A (38.1%) and Group B (41.2%) provided a similar significant ( p < 0.05) percentage reduction of MASI score, with no between‐group difference. The mMASI and IGA showed similar results. QoL and skin hydration significantly ( p < 0.05) improved in both groups after 6 months. Skin radiance and fine wrinkles also improved. Global tolerance was better with the DC routine.
Conclusions
Both DC routine and KT significantly improved melasma after 3 months of use. DC further improved melasma when replacing KT for 3 further months, with similar results when used alone for 6 months.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Dermatology & Aesthetics of Rio de Janeiro, Rio de Janeiro, Brazil.
- Vichy Laboratoires International, Vichy, France.
- Department of Dermatology, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil.
- L'Oréal, LDB, Rio de Janeiro, Brazil.
- Department of Dermatology, CHU Nice, Université Côte d'Azur, Nice, France.
- C3M, INSERM U1065, Université Côte d'Azur, Nice, France.
ORCID-Profile: Thierry Passeron
Zitieren
APA
Rocio, J., Kovylkina, N., Cestari, T., Feiges, M. F., Fernandes, E., Deloche-Bensmaine, C., Caberlotto, E., & Passeron, T. (2025). A Novel Dermocosmetic Routine Containing Vitamin B3 and 2‐Mercaptonicotinyl Glycine Significantly Improves Melasma After 3 Months of Daily Use. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70476
Vancouver
Rocio J, Kovylkina N, Cestari T, Feiges MF, Fernandes E, Deloche-Bensmaine C, et al. A Novel Dermocosmetic Routine Containing Vitamin B3 and 2‐Mercaptonicotinyl Glycine Significantly Improves Melasma After 3 Months of Daily Use. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70476
BibTeX
@article{Rocio2025,
author = {Rocio, Juliane and Kovylkina, Natalia and Cestari, Tania and Feiges, Mariana Fajgenbaum and Fernandes, Erika and Deloche-Bensmaine, Claire and Caberlotto, Elisa and Passeron, Thierry},
title = {A Novel Dermocosmetic Routine Containing Vitamin B3 and 2‐Mercaptonicotinyl Glycine Significantly Improves Melasma After 3 Months of Daily Use},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
doi = {10.1111/jocd.70476}
}
EUVIMED